Karuna Therapeutics, Inc., A Bristol Myers Squibb Company

This large, late-stage study is testing whether an investigational drug called KarXT can safely reduce distressing psychotic symptoms like hallucinations and delusions in people with Alzheimer's disease. It involves 500 participants aged 55-90 who have moderate to severe psychosi…